Liposomal Bupivacaine Injection 

Liposomal Bupivacaine Injection Overview

Effectively managing acute postoperative pain is a critical component of modern surgical care. Historically, extended pain control relied heavily on systemic opioids, which carry significant risks of respiratory depression, severe gastrointestinal issues, and the potential for long-term dependency. Liposomal Bupivacaine, widely known by the brand name Exparel, represents a major advancement in general medicine and surgical anesthesiology. By utilizing an advanced, sustained-release drug delivery system, this specialized injectable formulation provides prolonged, highly targeted local anesthesia directly at the surgical site.

What Is Liposomal Bupivacaine and How Does It Work?

Bupivacaine is a powerful amide-type local anesthetic that temporarily blocks the generation and conduction of nerve impulses. It achieves this by physically inhibiting voltage-gated sodium channels on the nerve membrane, preventing pain signals from reaching the brain. What makes this specific liposomal formulation unique is its advanced DepoFoam delivery system. Instead of entering the tissues all at once, the bupivacaine is encapsulated within microscopic lipid layers. 3. Is Liposomal Bupivacaine FDA Approved?

Yes, Liposomal Bupivacaine (Exparel) is fully FDA approved. It received its initial regulatory approval in (October 2011) and has since become a standard component of multimodal, opioid-sparing pain management protocols in surgical centers and hospitals globally.

What Is Liposomal Bupivacaine Used For?

• Local Surgical Site Infiltration: Injected directly into the tissues surrounding a surgical incision (such as in hemorrhoidectomies, bunionectomies, or abdominal surgeries) to provide localized, prolonged pain control.
• Interscalene Brachial Plexus Nerve Block: Administered precisely around the nerve bundle in the neck/shoulder area to provide prolonged regional numbness for major shoulder surgeries.
• Sciatic Nerve Block in the Popliteal Fossa: Used to temporarily block the sciatic nerve behind the knee, providing targeted, extended pain relief for lower leg, foot, or ankle surgeries.

Before Taking Liposomal Bupivacaine: Contraindications & Precautions

While local anesthetics are generally safe when confined to specific tissues, accidental injection directly into the systemic bloodstream or the central nervous system can be catastrophic. The cardiovascular system and the brain are highly sensitive to amide anesthetics. Before utilizing this extended-release formulation, the surgical team must thoroughly evaluate the patient’s overall cardiovascular health, liver function, and allergy history to prevent severe, unexpected medical complications during or immediately following the operation.

Who Should Not Take Liposomal Bupivacaine?

• Patients with a known, severe hypersensitivity or true allergic reaction to bupivacaine, any other amide-type local anesthetics (like lidocaine), or any lipid/excipient component in the formulation.
• Pregnant women requiring obstetrical paracervical block anesthesia, as the use of bupivacaine in this specific manner is strongly associated with severe fetal bradycardia (dangerously slow fetal heart rate) and death.
• Patients undergoing intravenous regional anesthesia (Bier block), as the medication must strictly remain outside of the vascular system.

Liposomal Bupivacaine, Pregnancy & Fertility

Classified as FDA Pregnancy Category C, this medication should be used during pregnancy only if the potential clinical benefits to the mother definitively outweigh the possible risks to the fetus. Bupivacaine is known to rapidly cross the placental barrier. While a localized injection minimizes systemic absorption, any significant amount reaching the fetal bloodstream can cause neonatal central nervous system depression or cardiovascular issues.

Tell Your Doctor Before Taking Liposomal Bupivacaine

Absolute transparency with your surgical team is essential prior to your operation. You must explicitly inform your surgeon and anesthesiologist if you have a known history of severe cardiovascular disease, heart block, or severe hepatic impairment, as your liver is entirely responsible for metabolizing and clearing the bupivacaine from your body once it is released.

Liposomal Bupivacaine Dosage & Administration

The dosing strategy for this specialized liposomal suspension is highly variable and entirely customized to the specific surgical procedure, the anatomical size of the surgical site, and the patient’s baseline health. It is never approached as a standardized, one-size-fits-all treatment. Dosing is uniquely calculated by the surgeon or anesthesiologist to utilize the exact volume necessary to saturate the surgical wound or surround the targeted nerve bundle without exceeding the absolute maximum safe limit.

Standard Liposomal Bupivacaine Dosing

• For local wound infiltration in adults, the dose is highly dependent on the size of the surgical defect, ranging from 106 mg (8 mL) for small incisions up to a strict maximum of 266 mg (20 mL) for large abdominal surgeries.
• For an interscalene brachial plexus nerve block or sciatic nerve block, the standard recommended dose is 133 mg (10 mL) carefully injected under ultrasound guidance.

How Liposomal Bupivacaine Is Administered

• The suspension is administered exclusively by a trained healthcare professional during surgery using a specialized technique called the “moving needle” technique to ensure the medication is evenly distributed throughout the tissues without accidentally piercing a blood vessel.
• The clinician must perform mandatory “aspiration” (pulling back on the syringe plunger) prior to injecting to absolutely ensure the needle is not resting inside a vein or artery.
• The liposomal suspension must not be rapidly injected or mixed indiscriminately with other common local anesthetics, as this can chemically rupture the liposomes and cause a dangerous, rapid release of the entire bupivacaine dose at once.

Liposomal Bupivacaine Clinical Efficacy & Research

Robust clinical trials and extensive real-world surgical applications have definitively established liposomal bupivacaine as a highly efficacious intervention for prolonged postoperative pain management. In randomized, double-blind clinical studies evaluating various surgeries, patients receiving Exparel demonstrated a statistically significant reduction in cumulative pain scores over the first 72 hours post-surgery compared to placebo groups.

Liposomal Bupivacaine Side Effects & Safety Profile

Introducing a powerful nerve-blocking agent into human tissue carries inherent safety risks. While strictly localized effects are intended, small amounts of the free bupivacaine eventually enter the systemic bloodstream as the liposomes degrade. This natural absorption can trigger mild temporary side effects.

Common Liposomal Bupivacaine Side Effects (>10%)

• Mild to moderate postoperative nausea and vomiting, which is highly common following general anesthesia and surgery.
• Constipation resulting from the combination of surgery, decreased mobility, and concurrent postoperative medications.
• A temporary, localized loss of motor function or mild muscle weakness directly around the injection site or the blocked nerve.

Serious Liposomal Bupivacaine Adverse Events

• Local Anesthetic Systemic Toxicity (LAST), presenting clinically as severe ringing in the ears, metallic taste, extreme dizziness, muscle twitching, or sudden grand mal seizures.
• Profound cardiovascular collapse, severe arrhythmias, or cardiac arrest if the medication enters the bloodstream rapidly.
• Severe hypersensitivity reactions or anaphylaxis, resulting in sudden airway constriction and profound drops in systemic blood pressure.

Managing Liposomal Bupivacaine Side Effects

Preventing and managing adverse effects requires meticulous surgical injection techniques and immediate postoperative vigilance. To prevent systemic toxicity, clinicians strictly aspirate the needle before injecting and utilize ultrasound guidance for nerve blocks. If a patient experiences early signs of LAST in the recovery room, such as a metallic taste or severe anxiety, the medical team is fully trained to administer immediate life support, supplemental oxygen, and specialized intravenous lipid emulsion therapy (Intralipid) to safely bind and neutralize the toxic anesthetic circulating in the blood.

Liposomal Bupivacaine Drug Interactions & What to Avoid

Because the DepoFoam liposomal delivery system is highly sensitive to chemical changes, mixing this medication with other common surgical drugs can be disastrous. Certain chemicals disrupt the fragile lipid layers, causing the immediate release of the 72-hour bupivacaine supply all at once, leading to an immediate, massive overdose.

Liposomal Bupivacaine Drug-Drug Interactions

• Non-Liposomal Lidocaine: Injecting standard lidocaine into the exact same surgical site simultaneously can cause an immediate structural breakdown of the Exparel liposomes, leading to a toxic bupivacaine release.
• Other Local Anesthetics: If additional non-liposomal bupivacaine is needed during the surgery, the total dose must be strictly mathematically calculated to ensure the combined milligram amount does not exceed safe systemic toxicity limits.
• Topical Antiseptics (e.g., Povidone Iodine): If the surgical tissue is heavily soaked in certain chemical antiseptics, they must be completely dried before the Exparel is injected, as the chemicals can destroy the liposomes on contact.

Liposomal Bupivacaine, Food & Alcohol

Because this medication is administered strictly while the patient is sedated or under general anesthesia in an operating room, preoperative fasting (NPO) guidelines are universally enforced. Patients are forbidden from consuming any solid foods, oral fluids, or alcohol for many hours prior to the surgery.

Liposomal Bupivacaine: Missed Dose, Overdose & Storage

This highly specialized liposomal formulation is strictly administered as a one-time intraoperative injection directly by a licensed surgical professional. Patients absolutely never self-administer this medication at home. Therefore, strict emergency protocols for toxicity management and rigorous pharmacy storage guidelines apply directly to the surgical facility rather than the individual patient.

Missed Dose of Liposomal Bupivacaine

Because this medication is only utilized proactively during a scheduled surgical procedure to prevent postoperative pain, the concept of a “missed dose” does not biologically apply. It is a single, intraoperative event.

Liposomal Bupivacaine Overdose & Emergency

A clinical overdose occurs if the absolute maximum volume is exceeded, if the liposomes are chemically ruptured, or if the fluid is inadvertently injected into a blood vessel. Symptoms present rapidly as intense anxiety, metallic taste, ringing in the ears, visual disturbances, followed rapidly by tremors, seizures, and severe cardiac depression.

How to Store Liposomal Bupivacaine

The glass vials must be stored securely in the hospital pharmacy refrigerator at strictly controlled temperatures between 36°F to 46°F (2°C to 8°C). The medication must never be frozen; freezing irreversibly destroys the fragile liposomes. If removed from refrigeration for surgical preparation, unopened vials can be safely stored at standard room temperature for a strict maximum of 30 days but must be discarded if not utilized within that exact timeframe.

Liposomal Bupivacaine Patient Management & Monitoring

The absolute cornerstone of safe local anesthetic administration is rigorous, continuous clinical observation in the post-anesthesia care unit (PACU). Even though the medication is designed to stay completely localized in the surgical wound, the attending healthcare providers must treat every major injection as a potential systemic event. By maintaining strict monitoring of the patient’s vital signs and neurological status as they wake up from surgery, the clinician can quickly identify the earliest subtle warning signs of systemic toxicity.

Tests Before Starting Liposomal Bupivacaine

• A comprehensive preoperative review of the patient’s baseline vital signs, focusing specifically on current resting blood pressure and electrocardiogram (ECG) results.
• Standard preoperative hepatic (liver) function blood tests to ensure the patient’s body can safely metabolize the anesthetic over the following three days.
• A thorough medication review by the anesthesiologist to identify any concurrent use of dangerous antiarrhythmic drugs.

Monitoring During Liposomal Bupivacaine Treatment

Following the surgery, the patient is intensely monitored in the recovery room. Nurses continuously observe the patient’s heart rate, blood pressure, and oxygen saturation on a cardiac monitor. As the patient regains consciousness, they are frequently assessed for any sudden changes in hearing, vision, or mental clarity that might indicate dangerous systemic toxicity.

Liposomal Bupivacaine Do’s and Don’ts

• DO strictly follow your surgeon’s instructions regarding postoperative wound care and physical mobility limits.
• DO inform your recovery nurse immediately if you wake up with severe ringing in your ears, a strange metallic taste, or intense dizziness.
• DON’T be alarmed if the surgical area remains entirely numb for up to three full days; this is the intended purpose of the extended-release medication.
• DON’T attempt to walk unassisted if you received a leg or ankle nerve block until a physical therapist clears you, as your leg muscles may remain temporarily weak.

Frequently Asked Questions

References

• U.S. FDA Label Information for Bupivacaine Liposome Injectable Suspension (Exparel).
• U.S. FDA Drugs@FDA – Application Number: 022496, Initial Approval Date: October 2011.

Legal Disclaimer

This educational guide is for general informational purposes only and does not substitute for professional medical advice, formal clinical diagnosis, or specialized surgical treatment. Always consult your attending surgeon, anesthesiologist, or qualified healthcare provider with specific questions regarding this anesthetic medication, your surgical procedure, or your customized pain management plan.